NITEï¼è£½åè©ä¾¡æè¡åºç¤æ©æ§ã¯ãæ°åã³ããã¦ã¤ã«ã¹ã®æ¶æ¯ç®çã§å©ç¨ãåºãã£ã¦ããã次äºå¡©ç´ é ¸æ°´ãã«ã¤ãã¦ãç¾æç¹ã§ã¯æå¹æ§ã¯ç¢ºèªããã¦ããªãã¨ããä¸éçµæãå ¬è¡¨ãã¾ãããå°é家ã¯ãå´é§ã§ã®ä½¿ç¨ã¯å®å ¨æ§ã«ã¤ãã¦ç§å¦çãªæ ¹æ ã示ããã¦ããªããªã©ã¨ãã¦ã注æãå¼ã³ããã¦ãã¾ãã æ¤è¨¼ã§ã¯ã2ã¤ã®ç 究æ©é¢ã§é ¸æ§åº¦ãå¡©ç´ ã®æ¿åº¦ãç°ãªã次äºå¡©ç´ é ¸æ°´ãæ°åã³ããã¦ã¤ã«ã¹ã®æ¶æ¯ã«æå¹ãã©ããã試é¨ãã¾ããã ãã®çµæãä¸é¨ã«ã¦ã¤ã«ã¹ã®ææåãå¼±ã¾ã£ãã¨ã¿ããããã¼ã¿ãããã¾ããããååãªå¹æãã¿ãããªããã¼ã¿ããããªã©ã°ãã¤ãã大ããæå¹æ§ã¯ç¢ºèªã§ããªãã£ãã¨ãããã¨ã§ããä»å¾ãå¡©ç´ æ¿åº¦ãé«ãããå ´åãªã©ã«ã¤ãã¦æ¤è¨¼ãç¶ããã¨ãããã¨ã§ãã ã¾ãNITEã§ã¯ã次äºå¡©ç´ é ¸æ°´ã¯å´é§ãããã¨ã§ç©ºéé¤èãã§ããã¨ãã¦è²©å£²ãããã±ã¼ã¹ãå°ãªããªããã¨ã«ã¤ãã¦ã人ä½ã¸ã®å®å ¨æ§ãè©ä¾¡ããç§å¦çãªæ¹æ³ã確ç«ãã¦ããªãã
ã2020å¹´6æ29æ¥ãããããããåãåãããåã³ãé¢é£è³æãã®æ´æ°ãçµäºãã¾ãããææ°ã®æ å ±ãæ¿åºè¦è§£ã¯ãæ°ãããã¥ã¼ã¹ãªãªã¼ã¹ãåçHPãåç §ãã ããã ã2020å¹´6æ9æ¥çºè¡¨è³æå·®ãæ¿ãããé¢é£è³æãã®ãã¡ããâ¡ã次äºå¡©ç´ é ¸æ°´ãçã®è²©å£²å®æ ã«ã¤ãã¦ï¼ãã¡ã¯ãã·ã¼ãï¼ãåã³ãâ¢ã次äºå¡©ç´ é ¸æ°´ãã®ç©ºéå´é§ã«ã¤ãã¦ï¼ãã¡ã¯ãã·ã¼ãï¼ããå·®ãæ¿ãã¾ããã ã2020å¹´6æ5æ¥çºè¡¨è³æå·®ãæ¿ãããé¢é£è³æãã®ãã¡ããâ¡ã次äºå¡©ç´ é ¸æ°´ãçã®è²©å£²å®æ ã«ã¤ãã¦ï¼ãã¡ã¯ãã·ã¼ãï¼ããå·®ãæ¿ãã¾ããã ã2020å¹´6æ2æ¥çºè¡¨è³æå·®ãæ¿ããããããããåãåãããã追è¨ãã¾ããã ï¼ç¬ï¼è£½åè©ä¾¡æè¡åºç¤æ©æ§ã§è¡ã£ã¦ããæ¶æ¯æ¹æ³ã®æå¹æ§è©ä¾¡ã«ã¤ãã¦ã第4åæ¤è¨å§å¡ä¼ãéå¬ãããæ°ãã«2種é¡ã®çé¢æ´»æ§å¤ããæ°åã³ããã¦ã¤ã«ã¹ã«å¯¾ãã¦æå¹ã¨å¤æããã¾ããã æ¬ä»¶æ¦è¦ æ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ã«å¯¾å¿ãã
1.ãã¯ãã«ï¼çã¨ãã® ãã¤ããªããå¼ 2.å¿«é©ãªéãã 3.å°ããªãåæ§ããã¦ãå®å¿ 4.ãããããæå ¥ã ãã¤ããªããå¼å 湿å¨ã¯ãé風ã®ï½¢æ°åå¼ï½£ã¨ãã¼ã¿ã¼ã§å 湿ãã¢ã·ã¹ããã「温風æ°åå¼ï½£ãçµã¿åãããæ¹å¼ã湿度ãä½ãã¨ãã¯ï½¢æ¸©é¢¨æ°åå¼ï½£ã§ãã¯ãã«ã«ãã°ããå 湿ãã¾ãã 湿度ã«å¿ãã¦2ã¤ã®æ¹å¼ãè³¢ã使ãåããã®ã§çã¨ãã§ãã
â»ãæ²è¼å½æï¼2020å¹´5æ8æ¥ï¼ã«ç¨ãã¦ãããè¦æçæåäºé ¸åå¡©ç´ æ°´æº¶æ¶²ãã«ã¤ãã¦ãå¡©ç´ ç³»ã®ã¬ã¹ãçæããä»ã®ç©è³ªï¼å®å®åäºé ¸åå¡©ç´ ã次äºå¡©ç´ é ¸ãªã©ï¼ã¨æ··åãé¿ããããããã®æ¶²å¤ã®ä¸»æåã§ãããäºå¡©ç´ é ¸ã¤ãªã³ããåå¿ç³»ã®å称ã«å«ãããè¦æçæåäºå¡©ç´ é ¸ã¤ãªã³æ°´æº¶æ¶²ãã«ä¿®æ£ãã¾ãããï¼2020å¹´7æ29æ¥è¿½è¨ï¼ ã»è¦æçæåäºå¡©ç´ é ¸ã¤ãªã³æ°´æº¶æ¶² (MA-T®) ãæ°åã³ããã¦ã¤ã«ã¹ã98%以ä¸æ¶æ¯ã§ãããã¨ãå®è¨¼ã ã»MA-T®ã¯ãæ ªå¼ä¼ç¤¾ã¨ã¼ã¹ããããéçºããé¤èã»æ¶èå¤ã®ã·ã¹ãã ã§ãæ¥æ¬ã®ã»ã¼å ¨ã¦ã®èªç©ºæ©ã®ã»ããå¤ãã®ããã«ã§ãå©ç¨ããã¦ããã2015å¹´ã«ã大éªå¤§å¦ã®ç 究ã«ãã£ã¦ãåå¿ãã¹ãèãã¦ã¤ã«ã¹ãåå¨ããæã«ã®ã¿ãå¿ è¦ãªéã ãäºé ¸åå¡©ç´ ã®æåãæ°´ã®ä¸ã§çæãããè¦æçæåäºå¡©ç´ é ¸ã¤ãªã³æ°´æº¶æ¶²ãã§ãããã¨ãæããã«ã ã»ããã¾ã§ã«ãMA-T®ã¯ãSARSã³ããã¦ã¤ã«ã¹ãMERSã³
æ°åã³ããã¦ã¤ã«ã¹ï¼SARS-CoV-2ï¼ã«å¯¾ããã¯ã¯ãã³ããä¸çä¸ããç±æããã¦ããã2020å¹´5æ22æ¥ã«ä¸çä¿å¥æ©é¢ï¼WHOï¼ãçºè¡¨ãããDraft landscape of COVID-19 candidate vaccinesãã«ããã°ãä¸çã§ã¯ã100åç®ä»¥ä¸ã®ã¯ã¯ãã³ã®éçºãé²ãããã¦ããã10åç®ã§è¨åºè©¦é¨ãå®æ½ããã¦ããããããªä¸ãã¯ã¯ãã³éçºã«è¿½ã風ã¨ãªãç¥è¦ãçºè¡¨ãããã æå¹ãªã¯ã¯ãã³ãéçºããããã«ã¯ãæ°åã³ããã¦ã¤ã«ã¹ææçï¼COVID-19ï¼ã®ç å ã«ã¤ãã¦ã®æ å ±ã ãã§ãªããææããæ£è ã®SARS-CoV-2ã«å¯¾ããå ç«å¿çã«é¢ããæ å ±ãå¿ è¦ã§ããããããããå ±åã¯ããã¾ã§ã»ã¨ãã©ç¡ãã£ããç¹ã«ãï¼1ï¼ææããæ£è ã®å ç«ç³»ã«ãã£ã¦SARS-CoV-2ã«å¯¾ãã¦ã©ã®ãããªå ç«å¿çãèªå°ããã¦ããã®ããï¼2ï¼ãã®å ç«å¿çã¯æç¶ããã®ããï¼3ï¼èªç¶çã«åå¨ããããããã
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}